This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

NGS Sample Preparation Market

NGS Sample Preparation Market

NGS Sample Preparation Market, Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2021 to 2031

NGS Sample Preparation Market
FACT5932MR
  • May-2021
  • List of Tables : 84
  • List of Figures : 112
  • 170 Pages
  • Healthcare

About the Report

The global NGS sample preparation market is expected to be valued at over US$ 4 billion by 2031, expanding at an astounding CAGR of around 16% over the next ten years. Sequencing-based surveillance is rapidly emerging as an effective way to detect various bacterial and viral strains, as well as numerous unaccounted pathogens.

Hence, next generation sequencing (NGS) is emerging as an effective approach to treat various infectious ailments. Moreover, prospects are likely to abound across chronic ailments as well, most notably in oncology and agrigenomics.

This new report by Fact.MR tracks global sales of NGS sample preparation products in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare domain in general, and demand for NGS sample preparation products in particular.

How Do Historical Sales & Future Projections Compare?

Rapid advancements in healthcare diagnostics technology have proved to be a boon for the global market, with countries investing in massive clinical and diagnostic laboratories to facilitate robust testing for a variety of chronic and infectious diseases.

Growth prospects further heightened amidst the COVID-19 pandemic, as healthcare providers effectively leveraged advanced in vitro diagnostic solutions and other testing approaches to ascertain infection presence amongst patients. Future prospects appear especially bright across the oncology segment.

How are Academic Level Collaborations Bolstering Growth Prospects?

While NGS is experiencing extensive uptake in clinical diagnostics, companies are faced with drawbacks in library preparation and different automation strategies. It has been found that pipetting workstations facilitate high throughput processing, but offer limited flexibility during procedures. This has led to the emergence of microfluidic solutions that offer great potential due to miniaturization and decreased investment costs.

Microfluidic systems are being used for automation. However, microfluidic systems are relatively new and only a handful of them are being commercialized. Hence, companies involved in NGS sample preparation are partnering with academic groups to advance in the field of microfluidic systems and pipetting workstations to assess its implementation in library preparation protocols.

Will NGS Sample Preparation Prove Useful in Tracking Plant Diseases?

NGS sample preparation is finding increasing applications in the agriculture sector, helping address various forms of plant and crop based diseases. Agricultural genomics, or agrigenomics, is continuing to drive sustainable productivity, offering solutions to mounting challenges of feeding the global population.

For instance, viral genomics is being extensively deployed to track outbreak of plant-based viral diseases which cause significant yield and quality losses in a wide variety of cultivated crops. Methods for simultaneous detection of multiple viruses have been developed, and NGS is now a principal focus of this area, as it enables unbiased and hypothesis-free testing of plant samples.

Avail customized purchase options for your needs

Why are Stringent Regulatory Approvals Impeding Market Expansion?

As NGS is a precision-based approach to diagnostics, sample preparation products to facilitate the same need to be in pristine condition. This reduced error margins and provides accurate results. For this, these products are subject to intense scrutiny by regulatory authorities.

Since every approval consumes a lot of time due constant requirements for compliance with various provisions often delays product launches, thus limiting adequate supply in the market. This is proving to be a significant growth staller in upcoming years.

ngs sample preparation market

Country-wise Analysis

How Lucrative are Growth Prospects for NGS Sample Preparation across the U.S.?

The presence of a robust healthcare system is primarily bolstering NGS sample preparation adoption prospects across the US. Presence of major clinical laboratories to understand disease progression and epidemiology using NGS is heightening adoption of various sample preparation products.

Bulk of NGS sample preparation products are expected to be utilized in the oncology domain, with prominent players such as Illumina Inc. working ceaselessly to develop NGS-based in vitro diagnostic solutions for cancer. Other prominent players include Bio-Rad Laboratories, Agilent Technologies and Thermo Fisher among others.

Why are NGS Sample Preparation Product Manufacturers Leaning towards India for Future Growth?

Over the years, the Indian healthcare industry has posted highly lucrative gains, with value-based care, smart healthcare and blockchain technology making significant strides. Moreover, NGS based testing has acquired major importance, given the rising complexities in chronic and infectious diseases.

Deployment of NGS screening has been overt in key areas such as non-invasive prenatal testing, cancer diagnostics and bacterial & viral infection diagnoses. Prenatal screening is a highly promising area as it can help conceiving couples determine presence of genetic disorders such as Down’s syndrome within the fetus.

An Adaptive Approach to Modern-day Research Needs

Category-wise Insights

Why are NGS Sample Preparation Kits, Reagents & Consumables in High Demand?

By product type, demand for NGS sample preparation kits, reagents & consumables is expected to embark on a positive trajectory, attributed to increased production volumes by leading manufacturers around the globe.

Prominent players, including Thermo Fisher Scientific Inc., QIAGEN N.V and Cytiva Life Sciences have emerged at the forefront of NGS sample preparation products, offering a wide range of kits, reagents & consumables.

How is Drug & Biomarker Discovery Opening up NGS Sample Preparation Application Prospects?

By application, the drug & biomarker discovery domain dominated the global NGS sample preparation market in 2019, a trend which is expected to continue across the forecast period. Recent innovations in drug and pharmaceutical ingredients development is majorly driving uptake.

NGS offers higher sensitivity, enabling detection of full genome sequence of pathogens, including unknown species. Applications of NGS for drug & biomarker discovery for oncology is especially potent, given the extremely high cancer prevalence rates.

Competitive Landscape

Offering new sampling products equipped with the latest technology, collaborations with existing manufacturers, acquisitions and securing regulatory approvals are some key expansion strategies relied upon by prominent market players. Some notable developments are:

  • In April 2021, QIAGEN N.V launched the QIAseq DIRECT SARS-CoV-2 Kit, a viral genome enrichment and library preparation solution to significantly reduce library turnaround times and plastics use for NGS
  • Also, Thermo Fisher Scientific approved a definitive agreement to acquire PPD Inc. at a purchase price of US$ 17.4 billion with the objective of enhancing innovation and increase drug development productivity and foster advanced clinical research
  • In May 2021, Integrated DNA Technologies (IDT) Inc. acquired Swift Biosciences to augment its NGS library preparation genomics kits for academic, translational and clinical research. IDT is a leader in developing and manufacturing nucleic acid products for academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, and synthetic biology, while Swift develops and commercializes NGS Library Prep Kits that maximize data output, provide comprehensive coverage, and reduce sequencing costs.

*This list is indicative- full details about prominent NGS sample preparation players is available upon request.

Interested to Procure The Data

Report Scope

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Countries Covered

  • US
  • Canada
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • China
  • India
  • Japan
  • Australia & New Zealand
  • GCC
  • South Africa
  • Brazil
  • Mexico

Key Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Profiled

  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Merck Millipore)
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Promega Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc. (Danaher Corporation)
  • New England Biolabs
  • Tecan Trading AG

Key Market Segments Covered

  • Product Type

    • NGS Sample Preparation Instruments
    • NGS Sample Preparation Kits, Reagents & Consumables
  • Application

    • NGS Sample Preparation for Drug & Biomarker Discovery
    • NGS Sample Preparation for Diagnostics
    • NGS Sample Preparation for Precision Medicines
    • Others
      • Agriculture
      • Animal Research
  • End User

    • Hospitals & Diagnostic Centers
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
    • Others
      • CROs
      • CMOs
  • Region

    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

- FAQs -

According to Fact.MR, the global NGS sample preparation market shall surpass a value of US$ 4 billion through 2031, expanding at a CAGR of around 16% throughout the forecast period
The drug & biomarker discovery domain is expected to emerge as the principal application area for NGS sample preparation
Markets in the Asia Pacific, most notably India and China, shall attract a major chunk of NGS sample preparation products investments by leading manufacturers
Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and F. Hoffmann-La Roche Ltd. are some prominent NGS sample preparation product manufacturers

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Lower Limb Arterial Stents Market

Lower Limb Arterial Stents Market research report covers detailed information on Global Lower Limb A...

Ocular Drug Delivery Technology Market

Ocular Drug Delivery Technology Market to register a CAGR 7.2% during the forecast period, 2020-2025...

Natural Cold, Cough, and Sore Throat Remedies Market

[170 Pages Report] Natural Cold, Cough, and Sore Throat Remedies Market research report categorizes ...

Bed headwall systems Market

Bed headwall systems Market research report covers detailed information on Global Bed headwall syste...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.